Michael Krainer

Department of Internal Medicine I - Division of Oncology, Medical University of Vienna

Affiliated withMedical University of Vienna

Research Area

Biography

Michael Krainer has not added Biography.
If you are Michael Krainer and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2021

Other Publications

Article	Year
Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer\| PubMed ID: 16270321	2005
Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. The Prostate\| PubMed ID: 17192910	2007
A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer. The Journal of urology\| PubMed ID: 17509302	2007
Linking the ovarian cancer transcriptome and immunome. BMC systems biology\| PubMed ID: 18173842	2008
BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment. Gynecologic oncology\| PubMed ID: 20189233	2010
The role of c-FLIP(L) in ovarian cancer: chaperoning tumor cells from immunosurveillance and increasing their invasive potential. Gynecologic oncology\| PubMed ID: 20227749	2010
Natural immunity enhances the activity of a DR5 agonistic antibody and carboplatin in the treatment of ovarian cancer. Molecular cancer therapeutics\| PubMed ID: 20371719	2010
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC cancer\| PubMed ID: 21129172	2010
Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression. Cancer\| PubMed ID: 21381010	2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22016507	2011
TUSC3 loss alters the ER stress response and accelerates prostate cancer growth in vivo. Scientific reports\| PubMed ID: 24435307	2014
Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study. PloS one\| PubMed ID: 24755958	2014
The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB. Leukemia & lymphoma\| PubMed ID: 25248880	2015
HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells. Molecular cancer research : MCR\| PubMed ID: 25349289	2015
Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma. BMC cancer\| PubMed ID: 25523155	2014
Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cel... International journal of cancer\| PubMed ID: 25735931	2015
The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma. PloS one\| PubMed ID: 26248232	2015
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 27400947	2016
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna. ESMO open\| PubMed ID: 27843624	2016
Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]\| PubMed ID: 28721510	2017
The European Society for Medical Oncology 'Magnitude of Clinical Benefit Scale' field-tested in infrequent tumour entities: an extended analysis of its feasibility at the Medical University ... ESMO open\| PubMed ID: 28761758	2017
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells. Oncotarget\| PubMed ID: 29416657	2018
Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 29636272	2018
Analysis of hematological parameters as prognostic markers for toxicity and survival of Radium treatment. Oncotarget\| PubMed ID: 29662636	2018
LUBAC and ABIN-1 Modulate TRAIL-Based NF-κB Induction in Human Embryonic Kidney 293 Cells. BioResearch open access\| PubMed ID: 29862142	2018
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified by genetic screens in yeast. Oncotarget\| PubMed ID: 30555636	2018
Synthetic lethality guiding selection of drug combinations in ovarian cancer. PloS one\| PubMed ID: 30682083	2019
Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database. European urology oncology\| PubMed ID: 31158090	2018
Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia. Prostate cancer and prostatic diseases\| PubMed ID: 31745255	2020
Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 31787484	2020
Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer. Cancers\| PubMed ID: 32120793	2020
Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J... European journal of cancer (Oxford, England : 1990)\| PubMed ID: 32605716	2020
Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European ... European journal of cancer (Oxford, England : 1990)\| PubMed ID: 32723589	2020
Impact of frailty on the management of patients with gynecological cancer aged 80 years and older. Archives of gynecology and obstetrics\| PubMed ID: 33009994	2021
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field. ESMO open\| PubMed ID: 33051192	2020
Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer. Translational research : the journal of laboratory and clinical medicine\| PubMed ID: 33197651	2021